Core Viewpoint - Jiangsu Qingquan Chemical Co., Ltd. has applied for a change in its listing review status to "inquired" on the Shenzhen Stock Exchange's ChiNext, aiming to raise 492.3 million yuan [1] Company Overview - Qingquan Co. specializes in the R&D, production, and sales of specialty fine chemicals and high-performance polymer materials, recognized as a national-level "little giant" enterprise focusing on advanced polymer materials and non-grain bio-based materials [1] - The company has developed a product system that includes new material monomers, green solvents, pharmaceutical and pesticide intermediates, and specialty polymer materials, with applications in various sectors such as aerospace, wind power, automotive, electronics, medical devices, chemicals, pharmaceuticals, and pesticides [1] Product and Market Position - The core products, including the new material monomer MACM and green solvent 2-MeTHF, have achieved high industry standards and are competitive against major industry players [2] - The global market share for MACM is estimated at 28% and for 2-MeTHF at 19% for the year 2024 [2] - The company has established partnerships with well-known domestic and international clients, including Zhangye Dagong, Grida Group, and Sinopec [2] Fundraising and Investment Plans - The funds raised from the IPO will be allocated to projects related to the company's main business, including the production of 5,000 tons of MACM and 4,000 tons of THF, as well as the construction of a research and development center [3] Financial Performance - Revenue for the years 2022, 2023, 2024, and the first half of 2025 is projected to be approximately 687 million yuan, 713 million yuan, 797 million yuan, and 396 million yuan respectively [3] - Net profit for the same periods is expected to be around 52.83 million yuan, 81.82 million yuan, 98.66 million yuan, and 57.91 million yuan [4] - Total assets and equity attributable to shareholders have shown fluctuations, with total assets at 1.023 billion yuan and equity at 706.95 million yuan as of June 30, 2025 [5]

Core Viewpoint - Jiangsu Qingquan Chemical Co., Ltd. has received acceptance for its IPO on the Shenzhen Stock Exchange's ChiNext board, aiming to raise approximately 492.3 million yuan [1] Company Overview - Qingquan Chemical specializes in the R&D, production, and sales of specialty fine chemicals and high-performance polymer materials, recognized as a national-level "little giant" enterprise focusing on specialized and innovative sectors [1] - The company has developed a product system that includes new material monomers, green solvents, pharmaceutical and pesticide intermediates, and specialty polymer materials, with applications in various industries such as aerospace, wind power, automotive, electronics, medical devices, chemicals, pharmaceuticals, and pesticides [1] Market Position - The company's core products, including the new material monomer MACM and the green solvent 2-MeTHF, have achieved high industry standards and are competitive against major industry players [1] - According to reports, Qingquan Chemical is projected to hold approximately 28% of the global market share for MACM and about 19% for 2-MeTHF in 2024 [1] Fundraising and Investment Plans - The funds raised from the IPO will be allocated to projects related to the company's main business, including: - A technical transformation project for producing 5,000 tons of MACM - A technical transformation project for producing 4,000 tons of THF - Construction of a research and development center - Supplementing working capital [2][3] Financial Performance - The company's revenue for the years 2022, 2023, 2024, and the first half of 2025 is projected to be approximately 687 million yuan, 713 million yuan, 797 million yuan, and 396 million yuan respectively, with net profits of 52.83 million yuan, 81.82 million yuan, 98.66 million yuan, and 57.91 million yuan [3] - As of June 30, 2025, total assets are expected to be around 1.023786 billion yuan, with equity attributable to shareholders of the parent company at approximately 706.95 million yuan [4] - The company has shown a decreasing asset-liability ratio from 44.03% in 2022 to an expected 24.63% in 2025, indicating improved financial stability [4]